maritide glp-1 Once Monthly Weight Loss Drug Shows High Discontinuation Rates in Phase II Trial GLP-1s unlocking keys to help

Wegovy (semaglutide 2.4 mg) is a prescription medicine licensed in the UK for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea

Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z, et al

However, please keep in mind everyone has different tolerances to caffeine

Understanding the difference between these older medications and GLP-1s, such as phentermine versus semaglutide or phentermine versus tirzepatide , can help you discuss options with your doctor

[ref] Circadian control of response to GLP-1: Like many hormones, there is a circadian aspect to GLP-1

10.1002/med.20142 21 MohsinS.BaniyasM